167 related articles for article (PubMed ID: 33939384)
21. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
22. Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia.
Knudsen MD; de Lange T; Botteri E; Nguyen DH; Evensen H; Steen CB; Hoff G; Bernklev T; Hjartåker A; Berstad P
World J Gastroenterol; 2016 Jul; 22(27):6276-86. PubMed ID: 27468217
[TBL] [Abstract][Full Text] [Related]
23. The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy.
Schroy PC; Coe AM; Mylvaganam SR; Ahn LB; Lydotes MA; Robinson PA; Davis JT; Chen CA; Ashba J; Atkinson ML; Colditz GA; Heeren TC
Cancer Prev Res (Phila); 2012 Aug; 5(8):1044-52. PubMed ID: 22689913
[TBL] [Abstract][Full Text] [Related]
24. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
[TBL] [Abstract][Full Text] [Related]
25. Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan.
Sakata N; Sakata Y; Shimoda R; Sakata H; Iwakiri R; Fujimoto K; Mizuguchi M; Irie H; Shimoda Y; Noshiro H
Hepatogastroenterology; 2014; 61(133):1224-8. PubMed ID: 25436287
[TBL] [Abstract][Full Text] [Related]
26. Incidence of Advanced Colorectal Neoplasia in Individuals With Untreated Diminutive Colorectal Adenomas Diagnosed by Magnifying Image-Enhanced Endoscopy.
Sekiguchi M; Otake Y; Kakugawa Y; Matsumoto M; Tomizawa Y; Saito Y; Matsuda T
Am J Gastroenterol; 2019 Jun; 114(6):964-973. PubMed ID: 31082873
[TBL] [Abstract][Full Text] [Related]
27. Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme.
van de Veerdonk W; Hoeck S; Peeters M; Van Hal G; Francart J; De Brabander I
United European Gastroenterol J; 2020 Mar; 8(2):185-194. PubMed ID: 32213071
[TBL] [Abstract][Full Text] [Related]
28. Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold.
Young GP; Woodman RJ; Symonds E
BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32994195
[TBL] [Abstract][Full Text] [Related]
29. Risk of metachronous neoplastic lesions during post-polypectomy surveillance in individuals with advanced colorectal neoplasia at initial screening colonoscopy.
Sekiguchi M; Kakugawa Y; Takamaru H; Yamada M; Sakamoto T; Saito Y; Matsuda T
J Gastroenterol Hepatol; 2021 Aug; 36(8):2230-2238. PubMed ID: 33626598
[TBL] [Abstract][Full Text] [Related]
30. Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific Regions.
Wong MC; Ching JY; Chiu HM; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Ng SC; Wu JC; Chan FK; Sung JJ
Am J Gastroenterol; 2016 Nov; 111(11):1621-1629. PubMed ID: 26977757
[TBL] [Abstract][Full Text] [Related]
31. Multitarget Stool RNA Test for Noninvasive Detection of Colorectal Neoplasias in a Multicenter, Prospective, and Retrospective Cohort.
Barnell EK; Kang Y; Barnell AR; Kruse KR; Fiske J; Pittz ZR; Khan AR; Huebner TA; Holmes FL; Griffith M; Griffith OL; Chaudhuri AA; Wurtzler EM
Clin Transl Gastroenterol; 2021 May; 12(5):e00360. PubMed ID: 34029233
[TBL] [Abstract][Full Text] [Related]
32. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
[TBL] [Abstract][Full Text] [Related]
33. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.
Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
Gut; 2014 Mar; 63(3):466-71. PubMed ID: 23964098
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and risk factors of colorectal neoplasia in individuals aged 40-49 years: Findings from screening program in China.
Zhang M; Zhang Y; Zhang W; Zhang Y; Zhao L; Jing H; Gao X; Nie Z; Zhu S; Zhang S; Zhang X
J Gastroenterol Hepatol; 2024 Apr; 39(4):694-700. PubMed ID: 38200678
[TBL] [Abstract][Full Text] [Related]
35. Predictors of advanced colorectal neoplasia for colorectal cancer screening.
Wong MC; Lam TY; Tsoi KK; Chan VC; Hirai HW; Ching JY; Sung JJ
Am J Prev Med; 2014 May; 46(5):433-9. PubMed ID: 24745632
[TBL] [Abstract][Full Text] [Related]
36. Comparison of multiple statistical models for the development of clinical prediction scores to detect advanced colorectal neoplasms in asymptomatic Thai patients.
Soonklang K; Siribumrungwong B; Siripongpreeda B; Auewarakul C
Medicine (Baltimore); 2021 May; 100(20):e26065. PubMed ID: 34011125
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens.
Wong MC; Ching JY; Chan VC; Lam TY; Shum JP; Luk AK; Wong SS; Ng SC; Ng SS; Wu JC; Chan FK; Sung JJ
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1472-9. PubMed ID: 25724708
[TBL] [Abstract][Full Text] [Related]
38. Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer.
Park CH; Kim NH; Park JH; Park DI; Sohn CI; Jung YS
Gastrointest Endosc; 2018 Jul; 88(1):128-135. PubMed ID: 29510145
[TBL] [Abstract][Full Text] [Related]
39. The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.
Kooyker AI; Toes-Zoutendijk E; Opstal-van Winden AWJ; Spaander MCW; Buskermolen M; van Vuuren HJ; Kuipers EJ; van Kemenade FJ; Ramakers C; Thomeer MGJ; Dekker E; Nagtegaal ID; de Koning HJ; van Leerdam ME; Lansdorp-Vogelaar I
Int J Cancer; 2020 Aug; 147(4):1098-1106. PubMed ID: 31853977
[TBL] [Abstract][Full Text] [Related]
40. Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study.
Imperiale TF; Monahan PO; Stump TE; Glowinski EA; Ransohoff DF
Ann Intern Med; 2015 Sep; 163(5):339-46. PubMed ID: 26259154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
